e-Participate

What is HRA Approval?

HRA Approval is the new approval that will be required for research to commence in the NHS in England. It is a new process that comprises a review by a Research Ethics Committee as well as an assessment of regulatory compliance and related matters undertaken by dedicated HRA staff.

Chronic headache, a headache occurring on 15 or more days per month for at least three months, is a common problem affecting around one in 30 of the population, and is a major cause of pain and disability. There is however currently very little information on the use of non-drug treatments or how to support people to manage their chronic headaches more effectively

A patient-centred analysis of how organisation constrains care coordination

(Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease) is a major multi-centre trial of allopurinol 600mg daily versus no treatment added to usual therapy in patients aged 60 years and over with ischaemic heart disease. The aim is to establish whether allopurinol improves cardiovascular outcomes in this population.

(Treatment In Morning vs Evening) is looking at patients taking once a day blood pressure medication, aiming to establish whether night time dosing is better (or worse) than morning time treatment in preventing heart attacks, strokes, and deaths related to diseases of the heart and circulation.

Achievements Over and Above

Well Done! Our thanks and congratulations go to a number of our research active practices for their enthusiasm and assistance in recruiting to studies.

Oxford University is surveying GP access to tests for cancer investigation across NHS England as part of a Cancer Research UK funded study. We aim to understand how test access varies between CCGs.